Clinical Outcome of Implantable Cardioverter Defibrillators With Recalled and Non-Recalled Leads in Japanese Patients : Increased Failure Rate of The Sprint Fidelis Lead
-
- Yanagisawa Satoshi
- Departments of Cardiology, Nagoya University Graduate School of Medicine Department of Cardiology, Chunichi Hospital
-
- Inden Yasuya
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Shimano Masayuki
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Yoshida Naoki
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Ichiyanagi Hiroshi
- Clinical Engineering, Nagoya University Graduate School of Medicine
-
- Fujita Masaya
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Ohguchi Shiou
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Ishikawa Shinji
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Kato Hiroyuki
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Okumura Satoshi
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Miyoshi Aya
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Nagao Tomoyuki
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Yamamoto Toshihiko
- Departments of Cardiology, Nagoya University Graduate School of Medicine
-
- Hirai Makoto
- Department of Cardiology, Nagoya University Graduate School of Health Science
-
- Murohara Toyoaki
- Departments of Cardiology, Nagoya University Graduate School of Medicine
書誌事項
- タイトル別名
-
- Clinical Outcome of Implantable Cardioverter Defibrillators With Recalled and Non-Recalled Leads in Japanese Patients
- – Increased Failure Rate of The Sprint Fidelis Lead –
この論文をさがす
抄録
Background: In recent years, there has been a series of recalls of popular implantable cardioverter defibrillators leads, and several reports have demonstrated an increasing rate of failure of such leads over time in Caucasian patients. However, little is known about the performance of these leads in Asian patients. The aim of this study was to investigate the rate of failure of the recalled leads and the characteristics as compared with non-recalled leads in Japanese patients. Methods and Results: A retrospective chart review was conducted in 214 patients (75 Sprint Fidelis, 8 Riata, and 131 Sprint Quattro leads) who underwent implantation and follow-up at Nagoya University Hospital. During the follow-up period, 14 Sprint Fidelis leads (19%) and 1 Riata lead (13%) failed, but no abnormality was found in the Sprint Quattro, non-recalled leads. Five patients (4 Sprint Fidelis and 1 Riata, 33% of lead failure patients) received inappropriate shocks. The 3-, 4-, and 5-year lead survival rates in Sprint Fidelis leads were 95.1% (95% confidence interval [CI]: 89.6%–100%), 89.8% (95% CI: 82.1%–97.6%), and 88.0% (95% CI: 79.6%–96.4%), respectively. A previous device implantation before Sprint Fidelis lead was the only significant predictor for lead fracture (hazard ratio, 5.33; 95% CI: 1.55–18.4; P=0.008). Conclusions: The rate of Sprint Fidelis lead failure continues to increase over time in Japanese patients. (Circ J 2014; 78: 353–359)<br>
収録刊行物
-
- Circulation Journal
-
Circulation Journal 78 (2), 353-359, 2014
一般社団法人 日本循環器学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282680084662528
-
- NII論文ID
- 130003382213
-
- NII書誌ID
- AA11591968
-
- COI
- 1:STN:280:DC%2BC2c7pvVamtA%3D%3D
-
- ISSN
- 13474820
- 13469843
-
- NDL書誌ID
- 025162466
-
- PubMed
- 24270680
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可